These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8532632)

  • 21. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
    Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L
    Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
    Spencer K; Coombes EJ; Mallard AS; Ward AM
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():506-18. PubMed ID: 1280026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of a sialic acid specific lectin-immunoassay for the measurement of human chorionic gonadotrophin glycoforms in serum and its application in normal and Down's syndrome pregnancies.
    Abushoufa RA; Talbot JA; Brownbill K; Rafferty B; Kane JW; Robertson WR
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):499-508. PubMed ID: 10762294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down's syndrome screening: value of using free beta-hCG.
    Densem J; Wald NJ
    Prenat Diagn; 1995 Jan; 15(1):94-5. PubMed ID: 7537881
    [No Abstract]   [Full Text] [Related]  

  • 25. Two-analyte assay for Down syndrome screening.
    Cavalli P
    Prenat Diagn; 1995 Jul; 15(7):680-1. PubMed ID: 8532633
    [No Abstract]   [Full Text] [Related]  

  • 26. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
    N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Down's syndrome. The role of intact hCG and free subunit measurement.
    Spencer K
    Scand J Clin Lab Invest Suppl; 1993; 216():79-96. PubMed ID: 7690984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimerization of urinary beta-core/hCFbetacf: a cause of poor beta-core assay performance in Down syndrome screening studies.
    Iles RK; Butler SA; Jacoby E
    Prenat Diagn; 1999 Aug; 19(8):790-2. PubMed ID: 10451534
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for Down syndrome using urine hCG free beta-subunit in the second trimester of pregnancy.
    Cole LA; Jacobs M; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MJ
    Prenat Diagn; 1997 Dec; 17(12):1107-11. PubMed ID: 9467807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal renal function as a cause of false-positive biochemical screening for Down's syndrome.
    Cararach V; Casals E; Martínez S; Carmona F; Aibar C; Quintó LI; Alonso P; Fortuny A
    Lancet; 1997 Nov; 350(9087):1295. PubMed ID: 9357411
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved parameters for risk estimation in Down's syndrome screening.
    Cuckle H
    Prenat Diagn; 1995 Nov; 15(11):1057-65. PubMed ID: 8606885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ; Watt HC; Hackshaw AK
    N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum screening for Down's syndrome.
    Bibby J; McCormack MJ
    Br J Obstet Gynaecol; 1994 Jun; 101(6):557-8. PubMed ID: 7517183
    [No Abstract]   [Full Text] [Related]  

  • 36. [A study on population-based prenatal screening and diagnosis of Down's syndrome in Jiangsu province].
    Liu QL; Hu YL; Xu ZF; Wang LJ; Sun Q; Lin N; Xu XY; Liu Y; Zhang JW; Tong JS; Wang XH; He J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):340-2. PubMed ID: 20533279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choice of serum markers in antenatal screening for Down's syndrome.
    Wald NJ; Watt HC
    J Med Screen; 1994 Apr; 1(2):117-20. PubMed ID: 8790499
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of free beta-hCG in Down's syndrome screening.
    Wald N; Hackshaw A; Haddow JE; Palomaki GE; Knight GJ
    Ann Clin Biochem; 1993 Sep; 30 ( Pt 5)():512-8. PubMed ID: 7504428
    [No Abstract]   [Full Text] [Related]  

  • 39. Maternal urinary beta-core hCG in chromosomally abnormal pregnancies in the first trimester.
    Kornman LH; Morssink LP; Wortelboer MJ; Beekhuis JR; De Wolf BT; Pratt JJ; Mantingh A
    Prenat Diagn; 1997 Feb; 17(2):135-9. PubMed ID: 9061761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system.
    Kublickas M; Crossley J; Aitken D
    Acta Obstet Gynecol Scand; 2009; 88(6):635-8, 7p following 638. PubMed ID: 19330568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.